EUVIMEDEUVIMED entdecken
Crossref

Aripiprazole and cariprazine in the augmentation of treatment-resistant depression: A review of efficacy, tolerability, and clinical applications

Konrad Puchalski, Cezary Orzechowski, Natalia Radwańska, Patrycja Janowiecka, Weronika Skoczek

Pharmacotherapy in Psychiatry and Neurology · 2025 · 41 (2) · 97-110

DOI: 10.5114/fpn.2025.159506 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacotherapy in Psychiatry and Neurology, 2025. Verfasst von Konrad Puchalski und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Puchalski, K., Orzechowski, C., Radwańska, N., Janowiecka, P., & Skoczek, W. (2025). Aripiprazole and cariprazine in the augmentation of treatment-resistant depression: A review of efficacy, tolerability, and clinical applications. Pharmacotherapy in Psychiatry and Neurology, 41(2), 97-110. https://doi.org/10.5114/fpn.2025.159506

Vancouver

Puchalski K, Orzechowski C, Radwańska N, Janowiecka P, Skoczek W. Aripiprazole and cariprazine in the augmentation of treatment-resistant depression: A review of efficacy, tolerability, and clinical applications. Pharmacotherapy in Psychiatry and Neurology. 2025;41(2):97-110. doi:10.5114/fpn.2025.159506

BibTeX
@article{Puchalski2025,
  author = {Puchalski, Konrad and Orzechowski, Cezary and Radwańska, Natalia and Janowiecka, Patrycja and Skoczek, Weronika},
  title = {Aripiprazole and cariprazine in the augmentation of treatment-resistant depression: A review of efficacy, tolerability, and clinical applications},
  journal = {Pharmacotherapy in Psychiatry and Neurology},
  year = {2025},
  volume = {41},
  number = {2},
  pages = {97--110},
  doi = {10.5114/fpn.2025.159506}
}
Kostenlos starten →